Loading clinical trials...
Loading clinical trials...
Evaluation of the change of serum Prolidase and Leptin values in the diagnosis and follow-up of osteomalacia and its clinical usability
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
TUĞBA ŞAHBAZ
NCT00024804 · Tumor Induced Osteomalcia, Osteomalacia, and more
NCT06202027 · FGF23-related Hypophosphataemic Rickets and Osteomalacia
NCT03775187 · X-linked Hypophosphatemia, Tumor-Induced Osteomalacia
NCT04045834 · PET / CT, PET / MR, and more
NCT01524016 · Oncogenic Osteomalacia, Mesenchymal Tumor
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions